文献速递血管炎

瑞典ANCA相关性血管炎患者长期生存:基于临床表型的聚类分析

Long-term patient survival in a Swedish population-based cohort of patients with ANCA-associated vasculitis.
PubMed 文献 · RMD Open · 2017-07-13

该研究基于瑞典南部70万居民区1997–2010年诊断的195例ANCA相关性血管炎(AAV)患者,按起病时器官受累分为胃肠道、心血管、非肾脏、肾脏伴PR3及肾脏不伴PR3五个聚类。中位随访4年(死亡者)和11年(存活者),1、2、5、10年生存率分别为87%、82%、70%、55%。心血管和胃肠道聚类死亡率最高;非肾脏聚类死亡率与一般人群无显著差异。

要点

  • AAV患者总体死亡率高于一般人群,但非肾脏聚类例外。
  • 心血管和胃肠道聚类死亡率最高。
  • 起病时临床表型(聚类归属)是生存的重要预测因素。

核心结论

  • AAV患者死亡率高于一般人群,但起病时无胃肠道、心血管或肾脏受累者不适用此结论。
  • 起病时临床表型是生存的重要预测因素。

研究设计与样本

  • 基于瑞典南部70万居民区1997–2010年诊断的195例AAV患者的人群队列研究,通过病历回顾评估结局。
  • 根据起病时器官受累将队列分为胃肠道、心血管、非肾脏、肾脏伴PR3及肾脏不伴PR3五个聚类。
  • 采用多变量模型检验聚类归属、人口学、临床和实验室指标对生存的预后价值。

主要发现

  • 195例患者(98例女性)诊断时中位年龄69岁(IQR 55–77)。
  • 98例(50%)随访期间死亡,其中位随访时间4年;存活者中位随访时间11年。
  • 1年、2年、5年、10年生存率分别为87%、82%、70%、55%。
  • 生存预后因素包括性别、年龄、肾功能和聚类归属。
  • 除非肾脏聚类外,AAV患者死亡率显著高于一般人群;心血管和胃肠道聚类死亡率最高。

临床怎么用

  • 起病时根据器官受累进行聚类分型有助于识别高死亡风险患者。
  • 对心血管和胃肠道聚类患者应加强监测和干预。
  • 非肾脏聚类患者死亡率与一般人群相近,治疗策略可相应调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with antineutrophil cytoplasmatic antibodies-associated vasculitides (AAV) exhibit higher mortality than the general population. In the current study, we assessed whether cluster affiliation based on clinical presentation might predict mortality. METHODS: With case record review, the outcomes for a population-based cohort of patients diagnosed with AAV in southern Sweden (catchment area of 0.7 million inhabitants) between 1997 and 2010 were assessed. Based on organ involvement at presentation, the cohort was stratified into the following clusters: gastrointestinal, cardiovascular, non-renal, renal with proteinase 3 (PR3) and renal without PR3. Cluster affiliation, demographics, clinical and laboratory values at entry were tested as prognostic factors for survival in multivariable models. RESULTS: 195 patients (98 female) with a median age of 69 years (IQR 55-77) at diagnosis were included in the cohort. The median time of follow-up was 4 years for the 98 patients (50%) who died during follow-up and 11 years for those alive at end of follow-up. The 1-year, 2-year, 5-year and 10-year survival was 87%, 82%, 70% and 55%, respectively. Prognostic factors for survival were sex, age, renal function and cluster affiliation. The mortality of patients with AAV was significantly increased compared with the general population except in the non-renal cluster. The cardiovascular and gastrointestinal clusters showed the highest mortality. CONCLUSION: Even though the mortality in patients with AAV is increased compared with the general population this does not apply to patients without gastrointestinal, cardiovascular or renal involvement at diagnosis. We suggest that the initial clinical presentation is an important predictor for survival.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Heijl C, Mohammad AJ, Westman K, et al. Long-term patient survival in a Swedish population-based cohort of patients with ANCA-associated vasculitis. RMD Open. 2017. PMID: 28955485. doi:10.1136/rmdopen-2017-000435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。